Intra-Cellular Therapies Inc
NASDAQ:ITCI
Income Statement
Earnings Waterfall
Intra-Cellular Therapies Inc
Revenue
|
464.4m
USD
|
Cost of Revenue
|
-33.7m
USD
|
Gross Profit
|
430.6m
USD
|
Operating Expenses
|
-590m
USD
|
Operating Income
|
-159.4m
USD
|
Other Expenses
|
19.7m
USD
|
Net Income
|
-139.7m
USD
|
Income Statement
Intra-Cellular Therapies Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
3
N/A
|
2
-15%
|
2
-17%
|
1
-32%
|
1
-54%
|
0
-33%
|
0
-25%
|
0
-33%
|
0
-50%
|
0
N/A
|
0
+100%
|
0
N/A
|
0
+50%
|
0
+33%
|
0
-25%
|
0
N/A
|
0
-33%
|
0
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+1 100%
|
3
+158%
|
11
+239%
|
23
+117%
|
38
+65%
|
56
+48%
|
71
+27%
|
84
+19%
|
103
+23%
|
139
+35%
|
188
+36%
|
250
+33%
|
311
+24%
|
366
+18%
|
420
+15%
|
464
+11%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(2)
|
(3)
|
(5)
|
(7)
|
(8)
|
(10)
|
(12)
|
(16)
|
(20)
|
(24)
|
(27)
|
(30)
|
(34)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
3
+180%
|
10
+243%
|
21
+118%
|
34
+64%
|
51
+47%
|
64
+27%
|
76
+19%
|
93
+23%
|
126
+35%
|
172
+36%
|
230
+34%
|
287
+25%
|
339
+18%
|
390
+15%
|
431
+10%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(29)
|
(28)
|
(24)
|
(25)
|
(32)
|
(49)
|
(66)
|
(92)
|
(106)
|
(112)
|
(122)
|
(120)
|
(119)
|
(118)
|
(105)
|
(98)
|
(103)
|
(112)
|
(133)
|
(152)
|
(162)
|
(162)
|
(162)
|
(155)
|
(154)
|
(168)
|
(195)
|
(221)
|
(252)
|
(270)
|
(290)
|
(325)
|
(362)
|
(398)
|
(450)
|
(474)
|
(494)
|
(526)
|
(538)
|
(563)
|
(590)
|
|
Selling, General & Administrative |
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(12)
|
(14)
|
(15)
|
(18)
|
(20)
|
(22)
|
(24)
|
(25)
|
(26)
|
(26)
|
(25)
|
(24)
|
(24)
|
(24)
|
(27)
|
(30)
|
(35)
|
(44)
|
(51)
|
(65)
|
(87)
|
(113)
|
(151)
|
(186)
|
(205)
|
(233)
|
(251)
|
(273)
|
(296)
|
(326)
|
(344)
|
(359)
|
(382)
|
(383)
|
(400)
|
(410)
|
|
Research & Development |
(23)
|
(21)
|
(16)
|
(16)
|
(21)
|
(37)
|
(52)
|
(77)
|
(88)
|
(93)
|
(100)
|
(96)
|
(94)
|
(92)
|
(79)
|
(74)
|
(79)
|
(89)
|
(109)
|
(125)
|
(132)
|
(126)
|
(118)
|
(104)
|
(89)
|
(80)
|
(82)
|
(71)
|
(66)
|
(65)
|
(57)
|
(74)
|
(89)
|
(103)
|
(124)
|
(130)
|
(135)
|
(144)
|
(155)
|
(163)
|
(180)
|
|
Operating Income |
(26)
N/A
|
(25)
+3%
|
(22)
+13%
|
(24)
-8%
|
(31)
-31%
|
(49)
-57%
|
(66)
-35%
|
(92)
-39%
|
(106)
-15%
|
(112)
-6%
|
(122)
-9%
|
(120)
+2%
|
(118)
+1%
|
(118)
+1%
|
(105)
+11%
|
(98)
+6%
|
(103)
-5%
|
(112)
-9%
|
(133)
-18%
|
(152)
-15%
|
(162)
-6%
|
(162)
+0%
|
(162)
N/A
|
(155)
+4%
|
(154)
+1%
|
(167)
-8%
|
(192)
-15%
|
(212)
-10%
|
(231)
-9%
|
(235)
-2%
|
(240)
-2%
|
(261)
-9%
|
(286)
-10%
|
(305)
-7%
|
(324)
-6%
|
(302)
+7%
|
(264)
+13%
|
(239)
+9%
|
(199)
+17%
|
(173)
+13%
|
(159)
+8%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
6
|
7
|
7
|
8
|
7
|
7
|
6
|
6
|
6
|
5
|
4
|
3
|
2
|
2
|
2
|
2
|
3
|
4
|
7
|
11
|
14
|
18
|
20
|
|
Pre-Tax Income |
(27)
N/A
|
(26)
+4%
|
(22)
+15%
|
(23)
-7%
|
(31)
-31%
|
(48)
-58%
|
(65)
-35%
|
(91)
-39%
|
(105)
-15%
|
(110)
-5%
|
(120)
-8%
|
(117)
+2%
|
(115)
+1%
|
(114)
+1%
|
(101)
+11%
|
(95)
+6%
|
(99)
-4%
|
(108)
-9%
|
(127)
-18%
|
(146)
-15%
|
(155)
-6%
|
(154)
+0%
|
(154)
N/A
|
(148)
+4%
|
(148)
+0%
|
(160)
-9%
|
(187)
-16%
|
(207)
-11%
|
(227)
-10%
|
(232)
-2%
|
(237)
-2%
|
(259)
-9%
|
(284)
-10%
|
(303)
-7%
|
(321)
-6%
|
(298)
+7%
|
(256)
+14%
|
(228)
+11%
|
(184)
+19%
|
(155)
+16%
|
(139)
+10%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
|
Income from Continuing Operations |
(27)
|
(26)
|
(22)
|
(23)
|
(31)
|
(48)
|
(65)
|
(91)
|
(105)
|
(110)
|
(120)
|
(118)
|
(116)
|
(116)
|
(103)
|
(95)
|
(99)
|
(108)
|
(127)
|
(146)
|
(155)
|
(154)
|
(154)
|
(148)
|
(148)
|
(160)
|
(187)
|
(207)
|
(227)
|
(232)
|
(237)
|
(259)
|
(284)
|
(303)
|
(321)
|
(298)
|
(256)
|
(228)
|
(184)
|
(155)
|
(140)
|
|
Net Income (Common) |
(27)
N/A
|
(25)
+6%
|
(22)
+13%
|
(23)
-7%
|
(31)
-31%
|
(48)
-58%
|
(65)
-35%
|
(91)
-39%
|
(105)
-15%
|
(110)
-5%
|
(120)
-8%
|
(118)
+2%
|
(116)
+1%
|
(116)
+1%
|
(103)
+11%
|
(95)
+7%
|
(98)
-3%
|
(106)
-9%
|
(126)
-18%
|
(145)
-15%
|
(155)
-7%
|
(154)
+0%
|
(154)
N/A
|
(148)
+4%
|
(148)
+0%
|
(160)
-9%
|
(187)
-16%
|
(207)
-11%
|
(227)
-10%
|
(232)
-2%
|
(237)
-2%
|
(259)
-9%
|
(284)
-10%
|
(303)
-7%
|
(321)
-6%
|
(298)
+7%
|
(256)
+14%
|
(228)
+11%
|
(184)
+19%
|
(155)
+16%
|
(140)
+10%
|
|
EPS (Diluted) |
-0.58
N/A
|
-0.95
-64%
|
-0.74
+22%
|
-0.79
-7%
|
-1.07
-35%
|
-1.57
-47%
|
-1.86
-18%
|
-2.58
-39%
|
-2.91
-13%
|
-2.55
+12%
|
-2.76
-8%
|
-2.72
+1%
|
-2.69
+1%
|
-2.67
+1%
|
-2.37
+11%
|
-2.2
+7%
|
-2.11
+4%
|
-1.94
+8%
|
-2.3
-19%
|
-2.66
-16%
|
-2.84
-7%
|
-2.81
+1%
|
-2.81
N/A
|
-2.68
+5%
|
-2.68
N/A
|
-2.46
+8%
|
-2.81
-14%
|
-2.97
-6%
|
-3.23
-9%
|
-2.87
+11%
|
-2.92
-2%
|
-3.18
-9%
|
-3.5
-10%
|
-3.27
+7%
|
-3.4
-4%
|
-3.15
+7%
|
-2.72
+14%
|
-2.41
+11%
|
-1.94
+20%
|
-1.62
+16%
|
-1.46
+10%
|